Skip to main content

Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) Investor Investigation of Takeover by Seattle Genetics, Inc

  • If you purchased shares of Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) and currently hold any of those NASDAQ:CASC shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors, who currently hold shares of Cascadian Therapeutics Inc (USA) (NASDAQ:CASC), was announced concerning whether the takeover of Cascadian Therapeutics Inc by Seattle Genetics, Inc for $10.00 per share is unfair to NASDAQ:CASC stockholders. The investigation by a law firm concerns whether certain officers and directors of Cascadian Therapeutics In...



You must register (for free) or login to view the entire investigation.